Renvela Related Clinical Trials
Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients [Recruiting]
The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan [Recruiting]
Sevelamer for Reducing Endotoxemia and Immune Activation [Completed]
A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722 [Completed]
Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis [Completed]
FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease [Completed]
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis [Terminated]
An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Patients With Chronic Kidney Disease [Completed]
An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients [Completed]
The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers [Completed]
Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD) [Withdrawn]
Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients [Completed]
Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis [Completed]
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease [Completed]
Sevelamer Hydrochloride in Peritoneal Dialysis Patients [Active, not recruiting]
Comparing Absorption of Dietary Phosphorus When Administering FOSRENOLŽ or RENVELAŽ in Healthy Adult Volunteers [Completed]
CARE-2 (Calcium Acetate [PhosLoŽ]/Sevelamer[RenagelŽ] Evaluation Study 2) for Heart Calcification in Dialysis Patients [Completed]
A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia [Completed]
Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD) [Completed]
Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease [Completed]
An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis [Completed]
The Effects of Sevelamer Carbonate on Diabetic Nephropathy [Completed]
Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4 [Recruiting]
Sevelamer in Proteinuric CKD [Recruiting]
Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients [Completed]
Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis [Completed]
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients [Active, not recruiting]
Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate [Not yet recruiting]
Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy [Completed]
A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (RenagelŽ) [Completed]
Study of Safety and Efficacy of RenagelŽ Compared With Calcium Acetate in Patients With Peritoneal Dialysis [Completed]
Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease [Completed]
Head to Head Study Against Sevelamer Hydrochloride [Completed]
FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease [Recruiting]
Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate [Completed]
Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride [Terminated]
Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis [Completed]
A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis [Completed]
Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing [Completed]
A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD [Completed]
Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion [Recruiting]
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2) [Recruiting]
Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease [Recruiting]
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1) [Recruiting]
Effect of Sevelamer on P-cresol Levels in CKD [Recruiting]
Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD [Completed]
Regulation of Bone Formation in Renal Osteodystrophy [Completed]
Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis [Completed]
Dialysis Clinical Outcomes Revisited (DCOR) Trial [Completed]
Effect of Bile Acid Sequestration on Postprandial GLP-1 Secretion, Glucose Homeostasis and Gut Microbiota [Recruiting]
A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis [Completed]
Reduce Cardiovascular Calcifications to Reduce QT Interval in Dialysis [Completed]
Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease [Completed]
A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis [Completed]
A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients [Completed]
A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients [Completed]
Study of Phosphate Levels in Patients With Chronic Kidney Disease [Completed]
Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder. [Completed]
A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia [Completed]
Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia [Completed]
A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia [Completed]
Ferric Citrate in Patients With End-Stage Renal Disease on Dialysis [Completed]
Optimal Anemia Treatment in End Stage Renal Disease (ERSD) [Not yet recruiting]
How Bone is Made in Children Receiving Dialysis [Recruiting]
Hypophosphatemic Rickets in Norway [Active, not recruiting]
Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals [Completed]
A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia [Completed]
A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease [Completed]
Pulmonary Hypertension Prevention in Hemodialysis [Not yet recruiting]
A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia [Completed]
Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis [Recruiting]
Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate [Completed]
PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs [Recruiting]
|